|
Name |
Preussilide E
|
Molecular Formula | C26H36O4 | |
IUPAC Name* |
methyl (2E,4E,6E)-7-[(1R,6R,8S,8aS)-2-[(2S)-2-hydroxypropyl]-3,6,8-trimethyl-7-oxo-5,6,8,8a-tetrahydro-1H-naphthalen-1-yl]-4,6-dimethylhepta-2,4,6-trienoate
|
|
SMILES |
C[C@@H]1CC2=CC(=C([C@@H]([C@H]2[C@@H](C1=O)C)/C=C(\C)/C=C(\C)/C=C/C(=O)OC)C[C@H](C)O)C
|
|
InChI |
InChI=1S/C26H36O4/c1-15(8-9-24(28)30-7)10-16(2)11-23-22(14-19(5)27)17(3)12-21-13-18(4)26(29)20(6)25(21)23/h8-12,18-20,23,25,27H,13-14H2,1-7H3/b9-8+,15-10+,16-11+/t18-,19+,20+,23+,25+/m1/s1
|
|
InChIKey |
CJDQRZHRJWJAGG-OXEMTIHYSA-N
|
|
Synonyms |
Preussilide E; CHEMBL4129629; J3.662.984C
|
|
CAS | NA | |
PubChem CID | 132489956 | |
ChEMBL ID | CHEMBL4129629 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 412.6 | ALogp: | 4.5 |
HBD: | 1 | HBA: | 4 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 63.6 | Aromatic Rings: | 2 |
Heavy Atoms: | 30 | QED Weighted: | 0.359 |
Caco-2 Permeability: | -4.567 | MDCK Permeability: | 0.00001500 |
Pgp-inhibitor: | 0.024 | Pgp-substrate: | 0.568 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.006 |
30% Bioavailability (F30%): | 0.006 |
Blood-Brain-Barrier Penetration (BBB): | 0.321 | Plasma Protein Binding (PPB): | 95.93% |
Volume Distribution (VD): | 2.576 | Fu: | 3.23% |
CYP1A2-inhibitor: | 0.369 | CYP1A2-substrate: | 0.468 |
CYP2C19-inhibitor: | 0.731 | CYP2C19-substrate: | 0.9 |
CYP2C9-inhibitor: | 0.791 | CYP2C9-substrate: | 0.291 |
CYP2D6-inhibitor: | 0.106 | CYP2D6-substrate: | 0.407 |
CYP3A4-inhibitor: | 0.913 | CYP3A4-substrate: | 0.733 |
Clearance (CL): | 13.599 | Half-life (T1/2): | 0.738 |
hERG Blockers: | 0.018 | Human Hepatotoxicity (H-HT): | 0.195 |
Drug-inuced Liver Injury (DILI): | 0.573 | AMES Toxicity: | 0.013 |
Rat Oral Acute Toxicity: | 0.908 | Maximum Recommended Daily Dose: | 0.9 |
Skin Sensitization: | 0.911 | Carcinogencity: | 0.858 |
Eye Corrosion: | 0.012 | Eye Irritation: | 0.017 |
Respiratory Toxicity: | 0.979 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003384 | 0.847 | D0B1IP | 0.293 | ||||
ENC003389 | 0.798 | D05QDC | 0.286 | ||||
ENC003387 | 0.688 | D0G3PI | 0.241 | ||||
ENC003386 | 0.688 | D02DGU | 0.241 | ||||
ENC003385 | 0.524 | D00DKK | 0.241 | ||||
ENC003854 | 0.317 | D0E9KA | 0.209 | ||||
ENC003853 | 0.317 | D0A7MY | 0.205 | ||||
ENC001871 | 0.267 | D0S7WX | 0.202 | ||||
ENC001877 | 0.267 | D0W2EK | 0.200 | ||||
ENC005575 | 0.264 | D0FG6M | 0.196 |